Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The American Glaucoma Society [[electronic resource] ] : its founding and first 25 years / / editors, M. Bruce Shields, George L. Spaeth
| The American Glaucoma Society [[electronic resource] ] : its founding and first 25 years / / editors, M. Bruce Shields, George L. Spaeth |
| Pubbl/distr/stampa | Amsterdam, The Netherlands, : Kugler Publications, 2010 |
| Descrizione fisica | 1 online resource (226 p.) |
| Disciplina | 615.7827 |
| Altri autori (Persone) |
ShieldsM. Bruce
SpaethGeorge L. <1932-> |
| Soggetto topico | Glaucoma - Societies, etc |
| Soggetto genere / forma | Electronic books. |
| ISBN | 90-6299-852-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PROLOGUE; 1 BEFORE THE AMERICAN GLAUCOMA SOCIETY; 2 THE GLAUCOMA LANDSCAPE AND THE ORIGINS OF THE AMERICAN GLAUCOMA SOCIETY; 3 THE BEGINNING OF THE BEGINNING(1985-1987); 4 GROWTH WITH A FIRM ETHICAL FOUNDATION (1988-1990); 5 AN EMPHASIS ON SCIENTIFIC EXCELLENCE (1991-1992); 6 SUPPORTING YOUNG SCIENTISTS(1993-1994); 7 EXPANDING OUR SCOPE AND SUPPORT (1995-1996); 8 A NEW ERA IN A TIME OF TURMOIL(1997-1998); 9 STRATEGIC PLANNING FOR A NEW MILLENNIUM (1999-2000); 10 STRENGTHENING OUR ETHICAL RELATIONS WITH INDUSTRY AND ADVANCING RESEARCH (2001-2002)
11 A CONGENIAL AND INCLUSIVE AGS PLANS FOR THE FUTURE (2003-2004)12 HONORING A RICH HERITAGE AND ADVANCING AN AGENDA OF PROMISE (2005-2006); 13 A FOUNDATION FOR THE FUTURE(2007-2008); 14 A CHRONICLE OF THE AMERICAN GLAUCOMA SOCIETY'S SCIENTIFIC MEETINGS (1987-2010); 15 RESEARCH AND FELLOWSHIPS; 16 HEALTH CARE POLICY AND ADVOCACY: EDUCATE, LEGISLATE AND COMMUNICATE; 17 The American Glaucoma Society andIts Relationship with the American Academy of Ophthalmology 18 DIVERSITY IN THE AMERICAN GLAUCOMA SOCIETY: HOW WELL HAS THE SOCIETY EMBRACED ITS MEMBERSHIP AND MIRRORED THE CHANGING DEMOGRAPHICS OF AMERICAN SOCIETY?19 A Canadian Presence in the American Glaucoma Society; 20 The American Glaucoma Society and International Glaucoma; ; APPENDIX I; APPENDIX II; APPENDIX III; APPENDIX IV; APPENDIX V; APPENDIX VI; INDEX OF AUTHORS |
| Record Nr. | UNINA-9910458161803321 |
| Amsterdam, The Netherlands, : Kugler Publications, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The American Glaucoma Society : its founding and first 25 years / / editors, M. Bruce Shields, George L. Spaeth
| The American Glaucoma Society : its founding and first 25 years / / editors, M. Bruce Shields, George L. Spaeth |
| Pubbl/distr/stampa | Amsterdam : , : Kugler Publications, , 2010 |
| Descrizione fisica | 1 online resource (ix, 206 pages) : illustrations, portraits |
| Disciplina | 615.7827 |
| Altri autori (Persone) |
ShieldsM. Bruce
SpaethGeorge L. <1932-> |
| Soggetto topico | Glaucoma - Societies, etc |
| ISBN | 90-6299-852-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PROLOGUE; 1 BEFORE THE AMERICAN GLAUCOMA SOCIETY; 2 THE GLAUCOMA LANDSCAPE AND THE ORIGINS OF THE AMERICAN GLAUCOMA SOCIETY; 3 THE BEGINNING OF THE BEGINNING(1985-1987); 4 GROWTH WITH A FIRM ETHICAL FOUNDATION (1988-1990); 5 AN EMPHASIS ON SCIENTIFIC EXCELLENCE (1991-1992); 6 SUPPORTING YOUNG SCIENTISTS(1993-1994); 7 EXPANDING OUR SCOPE AND SUPPORT (1995-1996); 8 A NEW ERA IN A TIME OF TURMOIL(1997-1998); 9 STRATEGIC PLANNING FOR A NEW MILLENNIUM (1999-2000); 10 STRENGTHENING OUR ETHICAL RELATIONS WITH INDUSTRY AND ADVANCING RESEARCH (2001-2002)
11 A CONGENIAL AND INCLUSIVE AGS PLANS FOR THE FUTURE (2003-2004); 12 HONORING A RICH HERITAGE AND ADVANCING AN AGENDA OF PROMISE (2005-2006); 13 A FOUNDATION FOR THE FUTURE(2007-2008); 14 A CHRONICLE OF THE AMERICAN GLAUCOMA SOCIETY'S SCIENTIFIC MEETINGS (1987-2010); 15 RESEARCH AND FELLOWSHIPS; 16 HEALTH CARE POLICY AND ADVOCACY: EDUCATE, LEGISLATE AND COMMUNICATE; 17 The American Glaucoma Society andIts Relationship with the American Academy of Ophthalmology 18 DIVERSITY IN THE AMERICAN GLAUCOMA SOCIETY: HOW WELL HAS THE SOCIETY EMBRACED ITS MEMBERSHIP AND MIRRORED THE CHANGING DEMOGRAPHICS OF AMERICAN SOCIETY?; 19 A Canadian Presence in the American Glaucoma Society; 20 The American Glaucoma Society and International Glaucoma; ; APPENDIX I; APPENDIX II; APPENDIX III; APPENDIX IV; APPENDIX V; APPENDIX VI; INDEX OF AUTHORS |
| Record Nr. | UNINA-9910791130403321 |
| Amsterdam : , : Kugler Publications, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Benefits of Natural Products for Neurodegenerative Diseases / / edited by M. Mohamed Essa, Mohammed Akbar, Gilles Guillemin
| The Benefits of Natural Products for Neurodegenerative Diseases / / edited by M. Mohamed Essa, Mohammed Akbar, Gilles Guillemin |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (XII, 496 p. 43 illus., 26 illus. in color.) |
| Disciplina | 615.7827 |
| Collana | Advances in Neurobiology |
| Soggetto topico |
Neurosciences
Alternative medicine Nutrition Complementary & Alternative Medicine |
| ISBN | 3-319-28383-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1 Dr. Ross Grant, Australasian Research Institute, Sydney, Australia Role of reseveterol on NAD metabolism in AD -- 2 Dr. Edwin Lim, Macquire University, Sydney, Australia Effect of edible items on Neurotransmitters during various brain diseases -- 3 Dr. Mohamed Essa, Sultan Qaboos University, Oman Marine products and their benefits on Parkinson’s disease pathology -- 4 Prof. Susan Mcguire, Loyalla University, Chicago, IL, USA Berries and Brain function -- 5 Dr. Mustaq A Memon, WSU. Pullman, USA Edible Natural products on Huntington’s disease -- 6 Dr. Mohamed Akbar, NIH, USA Curcumin and neurodegeneration -- 7 Dr. Annamalai Prakasam, MUSC, Charleston, USA Neuro nutrition -- 8 Ashfaq A Sheikh, NYSIBR, NY, USA Gingerol and neurodegenerative diseases -- 9 Dr. Mostafa Waly, Sultan Qaboos University, Oman Vitamin B12 and neurological disorders -- 10 Mrs. Layeeq Fatima, TAUB, Toronto, Canada Importance of natural products on brain functions -- 11 Dr. Mohammed Fayaz, University of Manitoba, Canada Nano technological approach of edible items for brain health -- 12 Dr. Mullaicharam, Oman Medical college, Oman Active phytochemicals and their benefit on Huntington’s disease -- 13 Dr. Nady Braidy, UNSW, Sydney, Australia Neuro protective effects of natural products on Ageing -- 14 Dr. Shanmugam Manoharan, Annamalai University, India Effect of nuts on brain ageing -- 15 Dr. Scendhilkumar P, Baylor College of Medicine, Texas, USA Effect of active compounds of vegetables on Brain -- 16 Dr. Kumar Ramsamy, UTCH, San Antanio, TX, USA Involvement of Food on brain health -- 17 Dr. Suthagar Ganapathy, Harvard University, Boston, USA Effect of Nuts and Fruits on Alzheimer models -- 18 Dr. Sengotuvelan Murugan, Rutgers University, NJ, USA Jamun and Neurodegenerative diseases -- 19 Prof. Samir Al-Adawi, Sultan Qaboos University, Oman Food and human Behavior -- 20 Dr. T. Manivasagam, Annamalai University, India Black tea polyphenols and Parkinson’s disease. |
| Record Nr. | UNINA-9910253893303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids / Vincenzo Di Marzo
| Cannabinoids / Vincenzo Di Marzo |
| Autore | DI MARZO, Vincenzo |
| Pubbl/distr/stampa | New York [etc.] : Kluwer Academic, 2004 |
| Descrizione fisica | 216 p. : ill. ; 23 cm |
| Disciplina | 615.7827 |
| Collana | Neuroscience Intelligence Unit |
| Soggetto topico | Canapa indiana - Uso terapeutico |
| ISBN | 0-306-48228-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990002209060203316 |
DI MARZO, Vincenzo
|
||
| New York [etc.] : Kluwer Academic, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cannabinoids / / edited by Vincenzo Di Marzo
| Cannabinoids / / edited by Vincenzo Di Marzo |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chichester, England : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (320 p.) |
| Disciplina | 615.7827 |
| Soggetto topico | Cannabinoids |
| ISBN |
1-118-45127-9
1-118-45128-7 1-118-45125-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Looking ahead after 50 years of research on cannabinoids / Raphael Mechoulam -- Cannabinoid receptor intracellular signaling : the long journey from binding sites to biological effects / Lawrence C. Blume, Khalil M. Eldeeb, and Allyn C. Howlett -- Endocannabinoid biochemistry : what do we know after 50 years? / Filomena Fezza and Mauro Maccarrone -- Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology / Beat Lutz -- Cannabinoids, endocannabinoids, and stress / Cecilia J. Hillard, Qing-song Liu, XiaoQian Liu, Bin Pan, Christopher J. Roberts, and Leyu Shi -- Cannabinoids and the brain : new hopes for new therapies / Javier Fernández-Ruiz, Mariluz Hernández, and Yolanda García-Movellán -- Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases : focus on tetrahydrocannabinol pharmacology / Paolo Caraceni, Francesca Borrelli, Ferdinando A. Giannone, and Angelo A. Izzo -- Years of cannabinoid research and the need for a new nomenclature / Vincenzo Di Marzo and Luciano De Petrocellis. |
| Record Nr. | UNINA-9910132192003321 |
| Chichester, England : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids / / edited by Vincenzo Di Marzo
| Cannabinoids / / edited by Vincenzo Di Marzo |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chichester, England : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (320 p.) |
| Disciplina | 615.7827 |
| Soggetto topico | Cannabinoids |
| ISBN |
1-118-45127-9
1-118-45128-7 1-118-45125-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Looking ahead after 50 years of research on cannabinoids / Raphael Mechoulam -- Cannabinoid receptor intracellular signaling : the long journey from binding sites to biological effects / Lawrence C. Blume, Khalil M. Eldeeb, and Allyn C. Howlett -- Endocannabinoid biochemistry : what do we know after 50 years? / Filomena Fezza and Mauro Maccarrone -- Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology / Beat Lutz -- Cannabinoids, endocannabinoids, and stress / Cecilia J. Hillard, Qing-song Liu, XiaoQian Liu, Bin Pan, Christopher J. Roberts, and Leyu Shi -- Cannabinoids and the brain : new hopes for new therapies / Javier Fernández-Ruiz, Mariluz Hernández, and Yolanda García-Movellán -- Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases : focus on tetrahydrocannabinol pharmacology / Paolo Caraceni, Francesca Borrelli, Ferdinando A. Giannone, and Angelo A. Izzo -- Years of cannabinoid research and the need for a new nomenclature / Vincenzo Di Marzo and Luciano De Petrocellis. |
| Record Nr. | UNINA-9910827773703321 |
| Chichester, England : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids / editor Roger G. Pertwee ; contributors M.E. Abood ...[et al.]
| Cannabinoids / editor Roger G. Pertwee ; contributors M.E. Abood ...[et al.] |
| Pubbl/distr/stampa | Berlin [etc.] : Springer, 2004 |
| Descrizione fisica | XII, 770 p. ; 24 cm |
| Disciplina | 615.7827 |
| Collana | Handbook of experimental pharmacology |
| Soggetto topico | Canapa indiana - Uso terapeudico |
| ISBN | 3-540-22565-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990001220900203316 |
| Berlin [etc.] : Springer, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cannabinoids - recent perspectives and applications in human health / / Steven James, editor
| Cannabinoids - recent perspectives and applications in human health / / Steven James, editor |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (152 pages) |
| Disciplina | 615.7827 |
| Soggetto topico |
Cannabis - Health aspects
Cannabinoids - Therapeutic use |
| ISBN | 1-80356-579-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Polysaccharide Chiral Stationary Phases for the Achiral and Chiral Separation of Cannabinoids -- By Weston J. Umstead -- 2. Cannabis Medicines: Guidance for the Selection, Purchase and Supply for Clinical Trials -- By Peter Galettis, John Barlow, Jaroslav Boublik, Stefania Capra, Rachel Galettis, Myfanwy Graham, Courtney Hill, Paul Mavor, Jasminka Nikolajevic-Sarunac, Rosemary Richards, Janet Schloss, Melinda Thompson, Linda Truong, Berzenn Urbi, Katrina Weston-Green and Aaron K. Wong -- 3. Perspective Chapter: Endocannabinoids in Renal Physiology - From Tissue Homeostasis to Precision Medicine -- By Gloria M.R.S. Grelle, Luzia S. Sampaio and Marcelo Einicker-Lamas -- 4. Cannabis and the Brain: Friend or Foe? -- By Ali E. Dabiri and Ghassan S. Kassab -- 5. Pediatric Brain on Cannabinoids: Adverse Effects of Cannabinoid Products in Children and Adolescents -- By Peter B. Chase -- 6. Evidence of Health Effects Associated with Marijuana Use: A Comprehensive Public Health Review -- By Richard Holdman. |
| Record Nr. | UNINA-9910727276903321 |
| London : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids and neuro-psychiatric disorders / / Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti, editors
| Cannabinoids and neuro-psychiatric disorders / / Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti, editors |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XVII, 153 p. 43 illus., 4 illus. in color.) |
| Disciplina | 615.7827 |
| Collana | Advances in experimental medicine and biology |
| Soggetto topico |
Cannabinoids
Molecular biology |
| ISBN | 3-030-57369-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910484969603321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids and pain / / Samer N. Narouze, editor
| Cannabinoids and pain / / Samer N. Narouze, editor |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (xix, 339 pages) : illustrations (black and white) |
| Disciplina | 615.7827 |
| Soggetto topico |
Cannabinoids - Therapeutic use
Pain - Chemotherapy Cànnabis Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
9783030691868
3-030-69186-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Part I: Introduction to Cannabis -- 1: History of Cannabis -- 2: Cannabis Regulations -- Introduction -- Federal Regulations -- State Cannabis Laws -- Research Expansion -- Conclusion -- 3: The Demand for Medical Cannabis Education -- 4: Pain Physicians and Medical Cannabis: Attitudes, Believes, Preparedness and Knowledge -- Introduction -- Development and Description of the Applied Questionnaire -- Statistical Analysis -- Results -- Discussion -- Summary -- Medical Cannabis Questionnaire -- 5: Cannabis Terminology -- Introduction -- General Aspects of the Cannabis Plant -- Differences Between C. sativa and C. indica -- Cannabis Versus Hemp -- The Endocannabinoid System (ECS) -- Key Terminology -- Cannabis Products and Accessories -- Conclusion -- Part II: Cannabinoids Pharmacology -- 6: The Endocannabinoid System -- Introduction -- Brief History of Cannabis and Hemp -- Components of the Endocannabinoid System (ECS) -- eCBs and Their Signal Transduction Pathways -- Complexity of the Endogenous Cannabinoid System -- CB1 and CB2 Receptor -- Other Receptors -- Transporters -- Enzymes -- Physiological Actions of ECS -- 7: Cannabinoid Receptor 1 (CB1) -- CB1 Receptors -- CB1 Receptor Physiology, Pathology, and Pharmacology -- CB1 Signaling -- CB1 Receptor Distribution -- Neocortex -- Hippocampus -- Hypothalamic -- Midbrain Periaqueductal Gray -- Brain Stem Rostral Ventromedial Medulla -- Tolerance -- CB1 Receptor Ligands -- References -- 8: Cannabinoid Receptor 2 (CB2) -- Cannabinoid 2 Receptor -- CB2 Receptor Physiology and Pharmacology -- CB2 Receptor Distribution -- CB2 Signaling -- CB2 Chronic Pain Models -- Tolerance -- CB2 Receptor Ligands.
9: Endocannabinoids: Anandamide and 2-Arachidonoylglycerol (2-AG) -- Introduction -- Biosynthesis and Breakdown Pathways -- Anandamide -- 2-AG -- Endocannabinoids' Mechanism of Action -- Anandamide -- 2-AG -- Plasticity of Endocannabinoid Signaling -- Endocannabinoids in Pain -- Peripheral Mechanisms -- Spinal Mechanisms -- Supraspinal Mechanisms -- Conclusion -- 10: Phytocannabinoids: Tetrahydrocannabinol (THC) -- Phytocannabinoids -- Introduction -- Δ9-Tetrahydrocannabinol (THC) -- Mechanism of Action of THC -- Applied Pharmacology and Pharmacokinetics -- Absorption -- Smoking -- Oral -- Oro-mucosal and Intranasal -- Rectal -- Transcutaneous -- Distribution -- Metabolism and Elimination -- Conclusion -- 11: Phytocannabinoids: Cannabidiol (CBD) -- Phytocannabinoids -- Cannabidiol and Its Various Clinical Effects -- Pharmacodynamics of Cannabidiol -- Applied Pharmacology and Pharmacokinetics -- Smoking -- Oral -- Transcutaneous -- Volume of Distribution -- Metabolism -- Elimination -- Safety Profile and Side Effects -- Cannabidiol Interaction with Tetrahydrocannabinol -- Conclusion -- 12: Other Phytocannabinoids -- Introduction -- Synthesis of Phytocannabinoids -- Cannabinoids and the Endocannabinoid System (ECS) -- Minor Cannabinoids -- Cannabinol (CBN) -- Cannabigerol (CBG) -- Cannabichromene (CBC) -- Tetrahydrocannabivarin (THCV) -- Conclusion -- 13: Cannabis Drug Interactions -- Introduction -- Routes of Administration -- Cannabinoid Drug Interactions -- Specific Drug Interactions -- Over-the-Counter (OTC) Analgesics -- Neuropathic Agents -- Opiates -- Antiepileptics -- Psychotropics -- Anticoagulants and Antiplatelets: "Blood Thinners" -- Warfarin -- Direct Oral Anticoagulants -- Clopidogrel -- Heparin/Fondaparinux -- References -- Part III: Pharmaceutical Cannabinoids. 14: Dronabinol (Marinol®) -- Introduction -- Mechanism of Action -- Pharmacokinetics -- Therapeutic Use -- Safety, Toxicity, and Adverse Effects -- 15: Nabilone (Cesamet) -- Introduction -- Clinical Trials -- Pharmacology and Pharmacokinetics -- Dosage and Administration -- Monitoring, Adverse Events, Drug Interactions, and Abuse Potential -- Adverse Effects -- Drug Interactions -- Abuse Potential -- 16: Cannabidiol (Epidiolex) -- Introduction -- Clinical Trials -- Pharmacology and Pharmacokinetics -- Dosage and Administration -- Monitoring, Adverse Events, and Drug Interactions -- Adverse Effects -- Abuse Potential -- 17: Nabiximols (Sativex®) -- Introduction -- Nabiximols Production -- Nabiximols Approval and Indications -- Nabiximols Contraindication -- Nabiximols Evidence -- Nabiximols for MS-Related Spasticity -- Nabiximols for MS-Related Neuropathic Pain -- Nabiximols for Cancer-Related Pain -- Nabiximols for Chronic Pain -- Nabiximols Tolerability -- Nabiximols Dosage and Administration -- Administration -- Dosing -- Storage, Stability, and Dosage Form -- Storage and Stability -- Dosage Form -- Summary -- Part IV: Medical Cannabis -- 18: Cannabis Strains to Chemovars -- Introduction -- Cannabis sativa L. -- Cannabis Cultivation and Trichomes -- Importance of Trichomes -- Cannabis Constituents -- Cannabinoids -- Terpenoids -- Other Cannabis Compounds -- Entourage Effect of Cannabis Constituents -- Cannabis Classification: Strains Versus Chemovars -- Strains -- Chemovar -- Practical Chemovar Selection for Clinicians -- Summary -- 19: The Model of a Medical Cannabis Clinic -- Introduction -- Description of a Medical Cannabis Clinic -- Referral and Screening -- Initial Visit -- Follow-Up and Monitoring -- Patient Education and Physician Communication. Protocols and Procedure Guidelines -- Continuing Medical Education -- Research Development -- Conclusion -- References -- 20: Barriers for the Prescription of Cannabinoid-Based Medicines -- Introduction -- Barriers for Cannabinoid Prescription -- Social Stigma for the Use of Cannabis -- Myths Versus Realities of Medical Cannabis Use -- Research Gaps and Limitations to Justify Medical Cannabis Use -- Lack of Knowledge Regarding Cannabis Regulatory Frameworks -- Limited Medical Cannabis Education -- Development of Medical Cannabis Education Programs with High Scientific Content -- Conclusion -- 21: Practical Recommendations for the Use of Medical Cannabis -- Introduction -- Cannabinoid-Based Medicines: What Is Currently Available? -- Prescription or Pharmaceutical Cannabinoids -- Natural Cannabis -- Inhalation -- Practical Recommendations [11, 12] -- Oral Administration -- Practical Recommendations [11, 12] -- Therapeutic Properties of Cannabinoids: THC Versus CBD -- Practical Recommendations for the Prescription of Cannabinoid-Based Medicines -- Clinical Evidence to Support Cannabinoid Use in Specific Medical Conditions -- Is the Patient a Candidate for Cannabinoid Therapy? A Systematic Approach -- Conclusion -- 22: Cannabinoid-Based Medicines: Dosing, Titration & -- Monitoring -- Introduction -- Methods of Administration -- Inhalation: Smoking and Vaporizing -- Oral -- Oromucosal -- Topical -- Dosing -- Concentration and Potency -- Cannabis Flower Dosing -- Cannabis Oil Dosing -- Achieving Optimal Therapeutic Dose and Cannabis Rotation -- Cannabis Chemovar Rotation and Reduction -- Monitoring -- Summary -- 23: Cannabinoid-Based Medicines: Patient Safety Considerations -- Introduction -- Practical Considerations for Cannabis Use -- Considerations -- Immunocompromised Patients. Calcineurin Inhibitors, Protein Disulfide Isomerase (PD1) Inhibitors, and Biologics -- Chronic Kidney Disease -- Older Adults and Patients with Concurrent Medical Conditions -- Polypharmacy and Drug Interactions [10] -- Precautions -- Concurrent Active Mood or Anxiety Disorder -- Patients with Risk Factors for Cardiovascular Disease (CVD) -- Tobacco Use -- E-Cigarette Use -- Severe Liver Dysfunction or Disease -- Medications Associated with Sedation or Cognitive Impairment -- Driving and Safety Sensitive Occupations -- Relative Contraindications -- Individuals Under the Age of 25 -- Cannabis Use Disorder (CUD) -- Substance Use Disorder (SUD) and Consideration for Harm Reduction -- Contraindications -- Cardiovascular Disease -- Respiratory Disease -- Psychosis and Bipolar Disorders -- Pregnancy and Breastfeeding -- Summary -- Part V: Cannabinoids and Pain -- 24: Cannabinoids and Pain: Mechanisms of Action -- Introduction -- Endocannabinoids' Mechanism of Action -- Anandamide (AEA) -- 2-Arachidonoylglycerol (2-AG) -- Endocannabinoids and Pain Modulation -- Peripheral Mechanisms -- Spinal Mechanisms -- Supraspinal Mechanisms -- Anandamide and 2-AG Synergistic Effect -- Endocannabinoid Receptors -- CB1 Receptors -- Central CB1 Receptors -- Peripheral CB1 Receptors -- Central CB2 Receptors -- Peripheral CB2 Receptors -- Other Putative Endocannabinoid Receptors: TRPV1 and GPR55 -- TRPV1 -- GPR55 -- Phytocannabinoids (THC and CBD) -- THC -- CBD -- Mechanisms of Action in Pain Modulation -- THC -- CBD -- References -- 25: Cannabinoids and Pain: Clinical Evidence -- Introduction -- Chronic Non-cancer Pain -- Chronic Neuropathic Pain -- Fibromyalgia -- Rheumatoid Arthritis -- Cancer Pain -- Acute Nociceptive Pain -- Summary -- 26: Cannabinoids and Cancer Pain -- Introduction -- Relevant Mechanisms of Cancer Pain. Current Understanding of Clinical Studies. |
| Record Nr. | UNINA-9910488702303321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
